Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
National Institutes of Health
About this archived opportunity
This Notice of Funding Opportunity seeks applications to establish and operate a dynamic and adaptable drug development infrastructure to support the research community. The aim is to strengthen and expand the substance use disorder (SUD) drug development pipeline by accelerating the evaluation and validation of repurposed and repositioned drugs. The Center and its team of subject matter experts will provide comprehensive drug development services to academic and biotech researchers at all stages of product development. By supporting various projects that address different SUD indications, the Center will contribute to reducing the burden of SUDs on individuals and communities. The services offered will include assistance in creating Target Product Profiles, Freedom-to-Operate analysis, intellectual property consultations, regulatory guidance, and technical pipeline support. Additionally, the Center will engage in outreach efforts to connect with the research community, solicit proposals, and implement processes to evaluate, select, and advance the projects focused on repurposing and repositioning medications for SUD treatment.
Historical details
- Status
- Closed
- Deadline
- January 28, 2026
- First captured
- December 17, 2025
- Publisher reference
- 359125
Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
This opportunity has closed
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
by National Institutes of Health
Get notified when similar opportunities open
We'll save this search and email you when new dynamic, adaptable, infrastructure opportunities are posted. Free.
Related opportunities
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver DiseasesHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses May 2029
- Industry Collaboration for the Kidney Precision Medicine Project (KPMP)HEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses in 74 days
- 2026 Balance of State Continuum of Care Program request for proposals now openWashington State Department of CommerceCloses in 5 days
- OTA Sources Sought - Asbestos Related Disease Screening - Libby, MTHEALTH AND HUMAN SERVICES, DEPARTMENT OF